302 related articles for article (PubMed ID: 24797980)
1. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
[TBL] [Abstract][Full Text] [Related]
2. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
3. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.
Reinehr T; Roth CL
J Clin Endocrinol Metab; 2008 Nov; 93(11):4479-85. PubMed ID: 18728159
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
5. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
6. Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease.
Pampanini V; Inzaghi E; Germani D; Alterio A; Puglianiello A; Alisi A; Nobili V; Cianfarani S
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):71-76. PubMed ID: 29122442
[TBL] [Abstract][Full Text] [Related]
7. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
8. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children.
Flisiak-Jackiewicz M; Bobrus-Chociej A; Tarasów E; Wojtkowska M; Białokoz-Kalinowska I; Lebensztejn DM
Can J Gastroenterol Hepatol; 2018; 2018():3870454. PubMed ID: 29854715
[TBL] [Abstract][Full Text] [Related]
9. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
10. Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.
Sato M; Kamada Y; Takeda Y; Kida S; Ohara Y; Fujii H; Akita M; Mizutani K; Yoshida Y; Yamada M; Hougaku H; Takehara T; Miyoshi E
Liver Int; 2015 Mar; 35(3):925-35. PubMed ID: 25627311
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
Radetti G; Kleon W; Stuefer J; Pittschieler K
Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
[TBL] [Abstract][Full Text] [Related]
14. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
15. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].
Romanowska A; Lebensztejn DM
Pol Merkur Lekarski; 2010 Jun; 28(168):459-61. PubMed ID: 20642104
[TBL] [Abstract][Full Text] [Related]
18. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
19. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
Huang SC; Yang YJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.
Torun E; Özgen IT; Gökçe S; Aydın S; Cesur Y
J Clin Res Pediatr Endocrinol; 2014; 6(1):34-9. PubMed ID: 24637308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
